Allogeneic hematopoietic stem cell transplantation for poor-risk CLL: dissecting immune-modulating strategies for disease eradication and treatment of relapse

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

John C. Byrd, Richard R. Furman, Steven Coutré et al. · New England Journal of Medicine · 2013 · 2.2K citations · Full text

Medicine, Hematology, Oncology +12

Defining the Intensity of Conditioning Regimens: Working Definitions

Andrea Bacigalupo, Karen K. Ballen, Doug Rizzo et al. · Biology of Blood and Marrow Transplantation · 2009 · 1.8K citations · Full text

Medicine, Hematology, Cell Therapy +9

Three-year follow-up of treatment-naïve and previously treated patients with CLL and SLL receiving single-agent ibrutinib

John C. Byrd, Richard R. Furman, Steven Coutré et al. · Blood · 2015 · 656 citations

Medicine, Pharmacology, Pharmacotherapy +8

Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia

Jennifer R. Brown, John C. Byrd, Steven Coutré et al. · Blood · 2014 · 584 citations · Full text

Medicine, Oncology, Pharmacology +14

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia

Andy C. Rawstron, Neus Villamor, Matthias Ritgen et al. · Leukemia · 2007 · 399 citations

Medicine, Hematology, Immunology +13